Margaret Davis is a Psychiatry physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
791 Chambers Rd
Aurora, CO 800117112
Telephone
303-617-2300Provider last certified this registry record 15 Mar 2021.
Clinical trials
- Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
Sponsor: Yale University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92.2%Atypical Antipsychotic29.1%Quetiapine Fumarate23%Risperidone18%Aripiprazole10%Olanzapine10%Paliperidone Er9%Ziprasidone Hcl8%Lurasidone Hcl5%Clozapine4%Vraylar4%Asenapine Maleate3%Quetiapine Fumarate Er2%Saphris1%Clozapine Odt1%Abilify Maintena1%Rexulti1%Part D<11 patientsSSRI13.3%Trazodone Hcl26%Sertraline Hcl22%Escitalopram Oxalate21%Fluoxetine Hcl11%Fluvoxamine Maleate8%Citalopram Hbr8%Paroxetine Hcl5%Part D<11 patients+ 21 more classes in this area
Cardiovascular
7%Central alpha-2 Adrenergic Agonist4.6%Clonidine Hcl64%Guanfacine Hcl Er36%Part D≥18 patientsBeta blocker1.6%Propranolol Hcl82%Propranolol Hcl Er19%Part D<11 patients+ 1 more class in this area
Hormonal (systemic)
0.3%Vasopressin Analog0.3%Desmopressin Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”